newsfilter
← Latest News
GlobeNewswire·

ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

Reported interim REGEN-007 data that demonstrate rilparencel's potential to preserve kidney function in patients with diabetes and advanced CKDRestarted manufacturing and resumed PROACT 1 and PROACT 2 Phase 3